Akiyama M, Alshehri W, Ishigaki S et al (2024) The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics. Immunol Med 1–13. https://doi.org/10.1080/25785826.2024.2407224

Akiyama M, Alshehri W, Ishigaki S et al (2025) Human T follicular helper cells and their impact on IgE and IgG4 production across allergy, malignancy, and IgG4-related disease. Allergol Int 74:25–32. https://doi.org/10.1016/j.alit.2024.07.005

Article  CAS  PubMed  Google Scholar 

Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31:529–533. https://doi.org/10.1080/14397595.2020.1859710

Article  CAS  PubMed  Google Scholar 

Suzuki K, Akiyama M, Saito K et al (2025) Isolated IgG4-related prostatitis masquerading as prostate cancer: a diagnostic pitfall in patients with elevated prostate-specific antigen and prostatic mass. Rheumatol Int 45:1–8. https://doi.org/10.1007/s00296-025-05960-x

Article  CAS  Google Scholar 

Li Z, Yan S, Zhang J et al (2025) Allergen-specific IgE and IgG4 signatures in IgG4-related disease revealed by a large-scale PhIP-seq study. https://doi.org/10.1111/all.70162. Allergy

Takanashi S, Akiyama M, Furuhashi K et al (2023) Distinct impact of malignancy and allergy on the clinical and immunological features of IgG4-related disease. https://doi.org/10.55563/clinexprheumatol/7g2na0. Clin Exp Rheumatol

Suzuki K, Akiyama M, Shimanuki K et al (2025) Co-occurrence of IgG4-related disease and mucous membrane pemphigoid: implication of shared IgG4-driven pathogenesis. Rheumatology (Oxford) keaf525. https://doi.org/10.1093/rheumatology/keaf525

Takanashi S, Akiyama M, Kondo Y, Kaneko Y (2024) Avoidance of allergen exposure May ameliorate IgG4-related disease: A case that improved spontaneously after moving house. Int J Rheum Dis 27:e14892. https://doi.org/10.1111/1756-185X.14892

Article  PubMed  Google Scholar 

Nagamura N, Imada T (2022) Anti-interferon-gamma autoantibody related disseminated nontuberculous mycobacteriosis with pathological features of Immunoglobulin G4-related disease. Immunol Med 45:48–53. https://doi.org/10.1080/25785826.2021.1914962

Article  PubMed  Google Scholar 

Kawano M, Yamada K, Kakuchi Y et al (2009) A case of Immunoglobulin G4-related chronic sclerosing sialadenitis and dacryoadenitis associated with tuberculosis. Mod Rheumatol 19:87–90. https://doi.org/10.3109/s10165-008-0127-z

Article  PubMed  Google Scholar 

Okazaki K, Kawa S, Kamisawa T et al (2022) Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020. J Gastroenterol 57:225–245. https://doi.org/10.1007/s00535-022-01857-9

Article  PubMed  PubMed Central  Google Scholar 

Daley CL, Iaccarino JM, Lange C et al (2020) Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis 71:e1–e36. https://doi.org/10.1093/cid/ciaa241

Article  PubMed  PubMed Central  Google Scholar 

Takeda K, Takazono T, Mukae H (2024) Drug-drug interactions in the management of non-tuberculous mycobacterial infections. Front Microbiol 15:1468383. https://doi.org/10.3389/fmicb.2024.1468383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benlidayi IC, Gupta L (2024) CAse-BAsed review sTandards (CABARET): considerations for authors, reviewers, and editors. J Korean Med Sci 39:e225. https://doi.org/10.3346/jkms.2024.39.e225

Article  PubMed  PubMed Central  Google Scholar 

Bajema KL, Daniel JC, Hussain S, Dworkin RJ (2014) IgG4-related pulmonary and salivary disease associated with pulmonary tuberculosis. Ann Am Thorac Soc 11:1165–1167. https://doi.org/10.1513/AnnalsATS.201406-229LE

Article  PubMed  Google Scholar 

Salahuddin A, Saif MW (2014) Pancreatic tuberculosis or autoimmune pancreatitis. Case Rep Med 2014:410142. https://doi.org/10.1155/2014/410142

Article  PubMed  PubMed Central  Google Scholar 

Lin S, Lin K, Lin AN et al (2017) Immunoglobulin G4-Related hepatic abscess with comorbid primary hepatic tuberculosis. Consultant 57:604–606

Google Scholar 

Qing P, Lu C, Liu Z et al (2021) IgG4-related disease with tuberculosis: A case report and retrospective review of patients in a single center. Front Immunol 12:652985. https://doi.org/10.3389/fimmu.2021.652985

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou F, Chu H, Xu Y et al (2024) Coexistence of Immunoglobulin G4-related kidney disease and acute hematogenous disseminated pulmonary tuberculosis: a case report. Front Immunol 15:1493754. https://doi.org/10.3389/fimmu.2024.1493754

Article  CAS  PubMed  Google Scholar 

Bae K, Jung An H, Jeon KN et al (2019) Coexistence of nontuberculous Mycobacterium and IgG4-related disease in a solitary pulmonary nodule: A case report: A case report. Med (Baltim) 98:e18179. https://doi.org/10.1097/MD.0000000000018179

Article  Google Scholar 

Akiyama M, Kaneko Y, Takeuchi T (2022) T follicular helper cells mediate local production of allergen-specific IgE and IgG4. J Allergy Clin Immunol 150:1045–1047. https://doi.org/10.1016/j.jaci.2022.05.003

Article  CAS  PubMed  Google Scholar 

Rispens T, Huijbers MG (2023) The unique properties of IgG4 and its roles in health and disease. Nat Rev Immunol 23:763–778. https://doi.org/10.1038/s41577-023-00871-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Starshinova A, Malkova A, Zinchenko Y et al (2022) Identification of autoimmune markers in pulmonary tuberculosis. Front Immunol 13:1059714. https://doi.org/10.3389/fimmu.2022.1059714

Article  CAS  PubMed  Google Scholar 

Ohrui T, Zayasu K, Sato E et al (2000) Pulmonary tuberculosis and serum ige: immune responses to M. tuberculosis down-regulate a Th2 immune response. Clin Exp Immunol 122:13–15. https://doi.org/10.1046/j.1365-2249.2000.01291.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araujo Z, Giampietro F, Rivas-Santiago B et al (2012) Patients exposed to Mycobacterium tuberculosis infection with a prominent IgE response. Arch Med Res 43:225–232. https://doi.org/10.1016/j.arcmed.2012.04.002

Article  CAS  PubMed  Google Scholar 

Krishnananthasivam S, Li H, Bouzeyen R et al (2023) An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis. NPJ Vaccines 8:127. https://doi.org/10.1038/s41541-023-00710-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akiyama M, Alshehri W, Saito K et al (2025) Pharmacological management of IgG4-related disease: from traditional to mechanism-based targeted therapies. Drugs Aging 42:111–126. https://doi.org/10.1007/s40266-024-01172-3

Article  CAS  PubMed  Google Scholar 

Yadlapati S, Verheyen E, Efthimiou P (2018) IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 38:169–177. https://doi.org/10.1007/s00296-017-3765-7

Article  CAS  PubMed  Google Scholar 

Hammitzsch A, Ferraro N, Bachmann Q et al (2026) Long-term treatment patterns and outcomes in IgG4-related disease - a retrospective single-center cohort study focusing on rituximab. Rheumatol Int 46:33. https://doi.org/10.1007/s00296-025-06065-1

Article  CAS  PubMed  PubMed Central  Google Scholar